Wijnand Helfrich

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Oxide Nanoparticles

Immune Response

Prostate Cancer

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells. Oncoimmunology 12 (1) (2023)
Isabel Britsch, Anne Paulien van Wijngaarden, Wijnand Helfrich
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy. Cancers 15 (15) (2023)
Emily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Isabel Britsch, Anne Paulien van Wijngaarden, Hao Zhang, Wijnand Helfrich
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR. Journal for immunotherapy of cancer 11 (9) (2023)
Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells. Oncoimmunology 12 (1) (2023)
Femke A van der Zant, Bob J L Kooijman, Judith E K R Hentzen, Wijnand Helfrich, Emily M Ploeg, Robert J van Ginkel, Barbara L van Leeuwen, Lukas B Been, Joost M Klaase, Patrick H J Hemmer, Christian S van der Hilst, Schelto Kruijff
Impact of cumulative complications on 1-year treatment-related healthcare costs in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. BJS open 6 (5) (2022)
Mark Alexander Johannes Martinus Hendriks, Isabel Britsch, Xiurong Ke, Anne Paulien van Wijngaarden, Douwe Freerk Samplonius, Emily Maria Ploeg, Wijnand Helfrich
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis. Oncoimmunology 10 (1) (2021)
Verena I Böhmer, Wiktor Szymanski, Keimpe-Oeds van den Berg, Chantal Mulder, Piermichele Kobauri, Hugo Helbert, Dion van der Born, Friederike Reeβing, Anja Huizing, Marten Klopstra, Douwe F Samplonius, Ines F Antunes, Jürgen W A Sijbesma, Gert Luurtsema, Wijnand Helfrich, Ton J Visser, Ben L Feringa, Philip H Elsinga
Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of 18 F-Labeled PSMA-Tracers for Prostate Cancer Imaging. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (47) (2020)
Mark Alexander Johannes Martinus Hendriks, Emily Maria Ploeg, Iris Koopmans, Isabel Britsch, Xiurong Ke, Douwe Freerk Samplonius, Wijnand Helfrich
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation. Oncoimmunology 9 (1) (2020)